Obesity linked to increased risk for pediatric multiple sclerosis

Obesity linked to increased risk for pediatric multiple sclerosis

(HealthDay)—Obesity seems to be associated with increased odds of pediatric multiple sclerosis (MS), according to a study published online July 15 in JAMA Neurology.

Brenda Huppke, M.D., from the University Medical Center Göttingen in Germany, and colleagues examined the correlation of obesity with pediatric MS risk and first-line therapy response in a retrospective study. A total of 453 patients with relapsing-remitting pediatric MS and a body mass index measurement taken within six months of diagnosis were included in the study.

The researchers found that 126 patients (27.8 percent) were overweight or obese at diagnosis, and obesity was associated with statistically significantly increased odds of MS in girls and boys (odds ratios, 2.19 and 2.14, respectively). Compared with nonoverweight patients, had statistically significantly more relapses on first-line with interferon beta and glatiramer acetate (annualized relapse rate, 1.29 versus 0.72) and a higher rate of second-line treatment (56.8 versus 38.7 percent).

"The findings do not indicate that promotes greater disease activity, but pharmacokinetic factors are more likely associated with treatment response," the authors write. "This suggestion may have relevant management implications given that a healthy weight may potentially optimize treatment outcomes and reduce disease-related burden and ."

Several authors disclosed financial ties to the pharmaceutical industry.


Explore further

Obesity linked to adverse events in children with leukemia

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Archives of Neurology

Copyright © 2019 HealthDay. All rights reserved.

Citation: Obesity linked to increased risk for pediatric multiple sclerosis (2019, July 16) retrieved 21 August 2019 from https://medicalxpress.com/news/2019-07-obesity-linked-pediatric-multiple-sclerosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more